{"brief_title": "Selegiline in Outpatient Treatment for Cocaine Dependence - 1", "brief_summary": "The purpose of this study is to evaluate the efficacy and clinical safety of selegiline in the treatment of cocaine dependence and to assess neurotoxicity (Magnetic Resonance Imaging, MRI) post-hoc as a possible variable for future stratification in clinical trials.", "condition": "Cocaine-Related Disorders", "intervention_type": "Drug", "intervention_name": "Selegiline", "criteria": "Inclusion Criteria: M/F ages 21-50. Meets DSM-IV criteria for cocaine. Agreeable to conditions of study and signed informed consent. Exclusion Criteria: Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.", "gender": "All", "minimum_age": "21 Years", "maximum_age": "50 Years", "healthy_volunteers": "No", "id": "NCT00000336.xml"}